Home
/
Products
/
Services
/
Resource
Citations Database
Download
/
News
News
/
Genomeditech
About
History
Honor
Contact
Careers
EN
EN
CN
Lentivirus
过表达慢病毒
干扰慢病毒
Cell Line Development
过表达细胞系构建服务
敲低细胞系构建服务
敲除细胞系构建服务
报告基因细胞株构建服务
Luciferase标记细胞株
Protein Expression
Plasmid DNA Preparation Services
过表达质粒构建
干扰质粒构建
突变/截短质粒构建
荧光素酶报告基因质粒构建
Adeno-associated Virus
过表达AAV
干扰AAV
Cell-based Assay
抗体Binding检测
蛋白/抗体药物功能检测
ADCC/P 活性检测
ADC药物CTG杀伤检测
CCK8细胞增值检测
克隆形成
细胞迁移/侵袭
细胞周期/凋亡
划痕实验
Antibody Services
Reporter Gene Detection Services
miRNA与靶基因调控研究
转录因子调控/promoter活性研究
Plasmid
Stock Plasmid
过表达现货
干扰现货
Reporter Plasmid
报告基因质粒-Luc
报告基因质粒-GFP
IPS相关质粒
自噬荧光单标质粒
空载体
细胞示踪质粒
Cell lines
Cytokines
Immune checkpoints
GPCR
CLDN
TAA
Kinase
TLR
NK
Antibody function
Immunotherapy target
In vivo imaging
TNF
LILR
WNT
Others
Reference cells
Molecular Reference Standards
gDNA
ctDNA
Reporter gene detection-related reagents
GMOne-Step
GMOne-Step 2.0
GMBright One-Step
GMSteady One-Step
双荧光素酶报告基因检测试剂盒
D-Luciferin
Lentivirus
过表达慢病毒
报告基因慢病毒
活体成像慢病毒
IPS相关慢病毒
永生化慢病毒
自噬慢病毒
CRE慢病毒
荧光对照慢病毒
Proteins
Cytokines
TAA
Immune checkpoints
Immunotherapy target
GPCR
TNF
Kinase
Others
Pseudovirus control material
Coronavirus-Like Pseudovirus
流感病毒类
副流感病毒类
呼吸道合胞病毒类
鼻病毒类
人偏肺病毒类
猴痘类
Reagents related to cell function detection and analysis
GMTiter TM Luminescent Cell Viability Assay
CCK8检测试剂盒
Adeno-Associated Virus (AAV)
光遗传
化学遗传
钙成像
Cre重组酶
常用对照
Antibodies
In Vivo MAb Antibodies
Isotype Control Antibody
Anti-Mouse Antibody
Anti-payload antibodies
Anti-payload antibodies
Positive control
Negative Control
Loading Controls Antibodies & Tag Antibodies
Loading Controls Anitibodies
Tag Antibodies
Biosimilar Antibodies
Cytokine
Immune checkpoint
TAA
Kinase
NK
Antibody function
Immunotherapy target
LILR
TNF
WNT
GPCR
CLDN
Others
Pseudovirus
SARS-CoV-2 pseudovirus
狂犬假病毒
非典假病毒
VSV假病毒
Influenza pseudovirus
Genoagent (Brand name of reagents)
lentiviral-packaging-tool
慢病毒包装试剂盒
慢病毒浓缩试剂盒
Transfection Reagent
GMTrans Liposomal Transfection Reagent
HG-TransGene transfection reagent
HG-Trans293 Transfection Reagent
支原体清除试剂
抗生素
基因敲除试剂盒
Polybrene（聚凝胺）
Switch-On Reagent
金黄色葡萄球菌肠毒素 E
search
Home
/
Products
/
Services
/
Resource
Citations Database
Download
/
News
/
Genomeditech
About
History
Honor
Contact
Careers
/
Contact
EN
EN
CN
Lentivirus
过表达慢病毒
干扰慢病毒
Cell Line Development
过表达细胞系构建服务
敲低细胞系构建服务
敲除细胞系构建服务
报告基因细胞株构建服务
Luciferase标记细胞株
Protein Expression
Plasmid DNA Preparation Services
过表达质粒构建
干扰质粒构建
突变/截短质粒构建
荧光素酶报告基因质粒构建
Adeno-associated Virus
过表达AAV
干扰AAV
Cell-based Assay
抗体Binding检测
蛋白/抗体药物功能检测
ADCC/P 活性检测
ADC药物CTG杀伤检测
CCK8细胞增值检测
克隆形成
细胞迁移/侵袭
细胞周期/凋亡
划痕实验
Antibody Services
Reporter Gene Detection Services
miRNA与靶基因调控研究
转录因子调控/promoter活性研究
Plasmid
Stock Plasmid
Reporter Plasmid
IPS相关质粒
自噬荧光单标质粒
空载体
细胞示踪质粒
Cell lines
Cytokines
Immune checkpoints
GPCR
CLDN
TAA
Kinase
TLR
NK
Antibody function
Immunotherapy target
In vivo imaging
TNF
LILR
WNT
Others
Reference cells
Molecular Reference Standards
gDNA
ctDNA
Reporter gene detection-related reagents
GMOne-Step
GMOne-Step 2.0
GMBright One-Step
GMSteady One-Step
双荧光素酶报告基因检测试剂盒
D-Luciferin
Lentivirus
过表达慢病毒
报告基因慢病毒
活体成像慢病毒
IPS相关慢病毒
永生化慢病毒
自噬慢病毒
CRE慢病毒
荧光对照慢病毒
Proteins
Cytokines
TAA
Immune checkpoints
Immunotherapy target
GPCR
TNF
Kinase
Others
Pseudovirus control material
Coronavirus-Like Pseudovirus
流感病毒类
副流感病毒类
呼吸道合胞病毒类
鼻病毒类
人偏肺病毒类
猴痘类
Reagents related to cell function detection and analysis
GMTiter TM Luminescent Cell Viability Assay
CCK8检测试剂盒
Adeno-Associated Virus (AAV)
光遗传
化学遗传
钙成像
Cre重组酶
常用对照
Antibodies
In Vivo MAb Antibodies
Anti-payload antibodies
Loading Controls Antibodies & Tag Antibodies
Biosimilar Antibodies
Pseudovirus
SARS-CoV-2 pseudovirus
狂犬假病毒
非典假病毒
VSV假病毒
Influenza pseudovirus
Genoagent (Brand name of reagents)
lentiviral-packaging-tool
Transfection Reagent
支原体清除试剂
抗生素
基因敲除试剂盒
Polybrene（聚凝胺）
Switch-On Reagent
金黄色葡萄球菌肠毒素 E
News
Insights
search
CN
Search
Home
Products
Plasmid
Cell lines
Molecular Reference Standards
Reporter gene detection-related reagents
Lentivirus
Proteins
Pseudovirus control material
Reagents related to cell function detection and analysis
Adeno-Associated Virus (AAV)
Antibodies
Pseudovirus
Genoagent (Brand name of reagents)
Services
Lentivirus
Adeno-associated Virus
Cell Line Development
Cell-based Assay
Plasmid DNA Preparation Services
Protein Expression
Antibody Services
Reporter Gene Detection Services
Resource
Citations Database
Download
News
News
Genomeditech
About
History
Honor
Contact
Careers
Get A Quote
News
Insights
Current position：
News
> News
News
TL1A：Teva and Sanofi Announce Duvakitug Positive Phase 2b Results Demonstrating Best-in-Class Potential in Ulcerative Colitis and Crohn’s Disease
2025-02-10
IL-23:FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease
2025-01-17
Amgen’s IMDYLLTRA®▼ (tarlatamab) Granted a Conditional Marketing Authorisation for Third-Line Treatment of Extensive-Stage Small Cell Lung Cancer in the United Kingdom
2025-01-17
GLP:Eden Unveils the World's First Compounded GLP-1 Rx Gummy
2025-01-10
TL1A:Teva and Sanofi Announce Duvakitug (Anti-TL1A) Positive Phase 2b Results Demonstrating Best-in-Class Potential in Ulcerative Colitis and Crohn’s Disease
2024-12-19
Merck Enters into Exclusive Global GLP-1：License Agreement with Hansoh Pharma for Investigational Oral GLP-1 Receptor Agonist
2024-12-19
ROR1：Merck Sharp & Dohme Initiates Phase III Clinical Trial of ROR1 ADC
2024-12-06
HER2：FDA signs off on Merus' first-in-class NRG1+ cancer drug Bizengri
2024-12-06
GLP-1：Amgen’s MariTide Demonstrates 20% Weight Loss
2024-11-28
IL-23：Protagonist Announces Positive Topline Results From Phase 3 ICONIC Studies of Icotrokinra
2024-11-19
First
1
2
Next
Last
Total 2 Page
Jump
Current position：
News
> News
classify
News
TL1A：Teva and Sanofi Announce Duvakitug Positive Phase 2b Results Demonstrating Best-in-Class Potential in Ulcerative Colitis and Crohn’s Disease
2025-02-10
IL-23:FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease
2025-01-17
Amgen’s IMDYLLTRA®▼ (tarlatamab) Granted a Conditional Marketing Authorisation for Third-Line Treatment of Extensive-Stage Small Cell Lung Cancer in the United Kingdom
2025-01-17
GLP:Eden Unveils the World's First Compounded GLP-1 Rx Gummy
2025-01-10
TL1A:Teva and Sanofi Announce Duvakitug (Anti-TL1A) Positive Phase 2b Results Demonstrating Best-in-Class Potential in Ulcerative Colitis and Crohn’s Disease
2024-12-19
Merck Enters into Exclusive Global GLP-1：License Agreement with Hansoh Pharma for Investigational Oral GLP-1 Receptor Agonist
2024-12-19
ROR1：Merck Sharp & Dohme Initiates Phase III Clinical Trial of ROR1 ADC
2024-12-06
HER2：FDA signs off on Merus' first-in-class NRG1+ cancer drug Bizengri
2024-12-06
GLP-1：Amgen’s MariTide Demonstrates 20% Weight Loss
2024-11-28
IL-23：Protagonist Announces Positive Topline Results From Phase 3 ICONIC Studies of Icotrokinra
2024-11-19
MORE
News
Insights
Message consultation
reset
submit
Service
Message
Message consultation
reset
submit
